SEVELAMER CARBONATE (SEVELAMER CARBONATE) — FDA Approval ANDA206234 (INVAGEN PHARMS)
SEVELAMER CARBONATE (SEVELAMER CARBONATE) — FDA Approval ANDA206234 (INVAGEN PHARMS) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: SEVELAMER CARBONATE; Active ingredients: SEVELAMER CARBONATE; Application number: ANDA206234.
| Brand name | SEVELAMER CARBONATE |
|---|---|
| Active ingredients | SEVELAMER CARBONATE |
| Application number | ANDA206234 |
| Sponsor | INVAGEN PHARMS |
| Dosage form | FOR SUSPENSION |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 2 |
| First approval date | 20240712 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →